SCHEMBL21596898

SCHEMBL21596898

COCc1cc(F)c(C#N)cc1C

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EGLN2 Q96KS0 6/20 0.41
KDM4E B2RXH2 7/20 0.40
ALDH1A1 P00352 6/20 0.40
HPGD P15428 6/20 0.40
HSD17B10 Q99714 5/20 0.40
GAA P10253 2/20 0.40
TRPV4 Q9HBA0 2/20 0.39
BACE1 P56817 1/20 0.37
ALOX15 P16050 1/20 0.36
APOBEC3G Q9HC16 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MAPT P10636 1/20 0.35
HTT P42858 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
NPSR1 Q6W5P4 1/20 0.34
MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18215048 0.86 TRPV4 (0.46) KDM4EALDH1A1HPGDHSD17B10GAA
SCHEMBL12763649 0.80 TRPV4 (0.42) EGLN2KDM4EALDH1A1TRPV4TDP1
SCHEMBL18500978 0.79 ALDH1A1 (0.41) KDM4EALDH1A1HPGDHSD17B10GAA
SCHEMBL21596899 0.79 TRPV4 (0.41) EGLN2TRPV4L3MBTL1MEN1KMT2A
Hydrochloric Acid SCHEMBL20840161 0.77 TRPV4 (0.40) EGLN2ALDH1A1TRPV4BACE1L3MBTL1
SCHEMBL16109779 0.76 MAPT (0.39) EGLN2KDM4EALDH1A1HPGDHSD17B10
SCHEMBL16082317 0.75 TRPV4 (0.52) EGLN2TRPV4
SCHEMBL15716060 0.75 ALDH1A1 (0.36) EGLN2KDM4EALDH1A1HPGDHSD17B10
SCHEMBL862662 0.73 TRPV4 (0.50) EGLN2TRPV4
SCHEMBL30583466 0.73 TRPV4 (0.50) EGLN2TRPV4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260062393-A1 Compounds CTXT PTY LTD (AU) 2026-03-05 US disclosed
US-12365655-B2 Compounds CTXT PTY LTD (AU) 2025-07-22 US disclosed
CN-112334466-B Compounds of formula (I) CTXT私人有限公司 2025-05-30 CN disclosed
EP-4335439-A2 COMPOUNDS CTXT PTY LTD (AU) 2024-03-13 EP disclosed
EP-3810602-B1 COMPOUNDS CTXT PTY LTD (AU) 2023-11-01 EP disclosed
EP-3810602-B1 COMPOUNDS CTXT PTY LTD (AU) 2023-11-01 EP disclosed
US-20220153710-A1 Compounds CTXT PTY LTD (AU) 2022-05-19 US disclosed
US-20220153710-A1 Compounds CTXT PTY LTD (AU) 2022-05-19 US disclosed
EP-3810602-A1 COMPOUNDS CTXT Pty Limited (AU) 2021-04-28 EP disclosed
US-20200039945-A1 Compounds CTXT PTY LIMITED (AU) 2020-02-06 US disclosed
WO-2019243491-A1 COMPOUNDS CTXT PTY LIMITED (AU) 2019-12-26 WO disclosed
WO-2019243491-A1 COMPOUNDS CTXT PTY LIMITED (AU) 2019-12-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220153710-A1 Compounds SLC10A1, ABCB11, PCSK9 EGLN2 612/4885KDM4E 4009/4885ALDH1A1 981/4885
US-20200039945-A1 Compounds SLC10A1, ABCB11, PCSK9 EGLN2 611/4885KDM4E 4009/4885ALDH1A1 982/4885
US-20260062393-A1 Compounds SCN2B, ABCB11, SCN1B EGLN2 2039/4885KDM4E 800/4885ALDH1A1 1864/4885
US-12365655-B2 Compounds SLC10A1, ABCB11, PCSK9 EGLN2 611/4885KDM4E 4009/4885ALDH1A1 982/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.